Sean O'Brien

No más puestos en curso

Health Technology

Consumer Services

Finance

Perfil

Mr. Sean O'Brien is an Analyst at YYC Capital Management LLC.
Prior to joining YYC Capital Management in June 2011, Mr. O'Brien was employed as a Principal by Eli Lilly & Co., an Associate by Advanced Tissue Sciences, Inc., Research Assistant by Vertex Pharmaceuticals, Inc., a Research Associate by Arena Pharmaceuticals, Inc., and an Assistant by The Salk Institute for Biological Studies.
Mr. O'Brien received his undergraduate degree in Finance from Suffolk University and an MBA from Suffolk University.

Antiguos cargos conocidos de Sean O'Brien.

Empresas	Cargo	Fin
YYC Capital Management LLC YYC Capital Management LLC Investment ManagersFinance Founded in 2009, YYC Capital Management LLC is a hedge fund manager located in New York City	Corporate Officer/Principal	01/09/2011
ELI LILLY AND COMPANY	Corporate Officer/Principal	31/10/2005
ARENA PHARMACEUTICALS	Corporate Officer/Principal	31/08/2003
Advanced Tissue Sciences, Inc.	Corporate Officer/Principal	30/11/2002
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	31/05/2002

Ver el detalle de la experiencia de Sean O'Brien.

Formación de Sean O'Brien.

Suffolk University

Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Sean O'Brien.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
ELI LILLY AND COMPANY	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology

Empresas privadas	3
YYC Capital Management LLC YYC Capital Management LLC Investment ManagersFinance Founded in 2009, YYC Capital Management LLC is a hedge fund manager located in New York City	Finance
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT.	Health Technology
Advanced Tissue Sciences, Inc.	Commercial Services

Ver las conexiones de la empresa